Skip to main content
Exit comparison
Removed
Added

Datasets Comparison

Version 1

Cutaneous malignancy after biologic therapy for inflammatory disease: an active comparator, retrospective cohort study supplementary material

Published:16 September 2024|Version 1|DOI:10.17632/ckhpky6dk8.1
Contributors:Kyle Lauck,
,
,
,
,

Description

Supplementary material for "Cutaneous malignancy after biologic therapy for inflammatory disease: an active comparator, retrospective cohort study." Legend: Mendeley supplemental figure 1. “Flow diagram of population inclusion criteria for active comparator analysis” Mendeley supplemental table I. “Index of biologic agents included in analysis”

Categories

Inflammatory Bowel Disease, Rheumatoid Arthritis, Biologic Therapy, Psoriasis, Epidemiology of Skin Cancer

Licence

Creative Commons Attribution 4.0 International

Version 2

Cutaneous malignancy after biologic therapy for inflammatory disease: an active comparator, retrospective cohort study supplementary material

Published:17 April 2025|Version 2|DOI:10.17632/ckhpky6dk8.2
Contributors:Kyle Lauck,
,
,
,
,

Description

Supplementary material for "Cutaneous malignancy after biologic therapy for inflammatory disease: an active comparator, retrospective cohort study." Legend: Mendeley supplemental figure 1. “Flow diagram of population inclusion criteria for active comparator analysis” Mendeley supplemental table I. “Index of biologic agents included in analysis”

Categories

Inflammatory Bowel Disease, Rheumatoid Arthritis, Biologic Therapy, Psoriasis, Epidemiology of Skin Cancer

Licence

Creative Commons Attribution 4.0 International